Complement C3 vs C5 inhibition in severe COVID-19: Early...

Clinical Immunology 2020 / 11 Vol. 220

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Mastellos, Dimitrios C., Pires da Silva, Bruno G.P., Fonseca, Benedito A.L., Fonseca, Natasha P., Auxiliadora-Martins, Maria, Mastaglio, Sara, Ruggeri, Annalisa, Sironi, Marina, Radermacher, Peter, Ch
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
220
Journal:
Clinical Immunology
DOI:
10.1016/j.clim.2020.108598
Date:
November, 2020
File:
PDF, 2.56 MB
2020
Conversion to is in progress
Conversion to is failed